Fermin Orgambide - Spark Newswire

1 minute read

Psyched Wellness CEO Buys This Many Shares In The Open Market

Today, 2:04 AM

Jeffrey Stevens, the CEO and co-founder of Psyched Wellness (OTCQB: PSYCF), has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $31,750).

PSYCF

1 minute read

Silo Wellness Enters Financing Arrangement With Alpha Blue Ocean

By Fermin Orgambide

Today, 2:04 AM

Silo Wellness (OTCQB: SILFF), a publicly-traded company that offers psychedelic retreats in Jamaica, has announced that the investing firm Alpha Blue Ocean has managed a CA$5,950,000 (around $4,720,000) financing arrangement for the company.

SILFF

1 minute read

Mydecine Announces 1-for-50 Reverse Stock Split

By Fermin Orgambide

Today, 2:04 AM

The board of directors of Mydecine Innovations Group Inc. (OTCPK:MYCOF) voted in favor of completing a reverse stock split. With this action, the company will consolidate all issued and outstanding shares on a base of 1-for-50. According to Mydecine, the consolidation is expected to reduce the number of common shares from 268,515,954 to 5,370,319.

MYCOF

1 minute read

Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin

By Fermin Orgambide

Today, 2:04 AM

Filament Health Corp. (OTCQB: FLHLF) announced that the U. S. Patent and Trademark Office (USPTO) issued a patent that will allow the company to extract and standardize natural psilocybin and associated psychedelic compounds.

FLHLF

2 minute read

Cybin’s CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics

By Fermin Orgambide

Today, 2:04 AM

CYB004 is one of Cybin’s (NYSE:CYBN) proprietary second-generation psychedelics, developed to treat depression, anxiety, and substance abuse disorders.…

CYBN